COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
批准号:
10285380
负责人:
TED ROSS
金额:
$96.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2021-08-19
关键词:
2019-nCoVAnimal ModelAnimalsContractorContractsCoronavirusElderlyHumanImmuneImmune responseImmunityIndividualMucous MembraneNational Institute of Allergy and Infectious DiseaseObesityRecording of previous eventsUnited States National Institutes of HealthVaccinatedVaccinesanti-influenzacoronavirus diseasedesignhigh riskhigh risk populationimmunogenicityinfluenza virus vaccineinnovationnext generationnovel vaccinespregnantprogramsresponseseasonal influenzastandard of careuniversal influenza vaccineuniversal vaccinevaccine development
中文摘要
该合同计划的目标是支持提高季节性流感疫苗、SARS-COV-2疫苗的免疫原性和持久性,并支持开发创新的流感疫苗方法,提供强大、持久、广泛保护的粘膜和系统抗流感免疫(“通用流感疫苗”)。
英文摘要
The objective of this contract program is to support improvements in the immunogenicity and durability of seasonal influenza vaccines, SARS-COV-2 vaccines and the development of innovative influenza vaccine approaches that provide robust, durable, broadly protective mucosal and systemic anti-influenza immunity (“universal influenza vaccines”).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10242598
-
项目类别:
-
资助金额:$1074.98万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10021763
-
项目类别:
-
资助金额:$800.0万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10788197
-
项目类别:
-
资助金额:$1070.0万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10621131
-
项目类别:
-
资助金额:$1018.84万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
-
批准号:10621132
-
项目类别:
-
资助金额:$222.94万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10455390
-
项目类别:
-
资助金额:$1227.56万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
-
批准号:10287647
-
项目类别:
-
资助金额:$96.97万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
-
批准号:10621133
-
项目类别:
-
资助金额:$6.11万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
-
批准号:10455392
-
项目类别:
-
资助金额:$157.59万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
海外基金